Results

Our proven
track record.

  • We represented a University in its spinout of a biopharmaceutical company and subsequent $32 million Series A financing, including an agreement granting exclusive rights to acquire the company and its technology.
  • We represented a specialty pharmaceutical client in its collaboration with a Chinese pharmaceutical company to develop and manufacture pharmaceutical products in China.
  • Our lawyers represented a Singapore-based public company in its joint venture with a privately held U.S. company to develop and market hardware and software products for postal, courier, and logistics markets.
  • We have negotiated joint development agreements with US, Swiss, Canadian, and Chinese pharmaceutical companies relating to both new compounds and generic versions of listed drugs on behalf of biotech and specialty pharmaceutical companies.
  • We represented a U.S. manufacturer in a joint venture with a Chinese partner for the construction of a manufacturing facility in Shanghai.
  • We represented a leading Canadian provider of diagnostic imaging technology in negotiating a series of arrangements to distribute its technology in conjunction with the products of the world’s top medical imaging equipment manufacturers.
  • We represented a U.S.-based pharmaceutical company and its India-based subsidiary in numerous licensing and joint venture transactions with major educational and government organizations in India and represented them in its sale to a British entity. Currently, we represent a principal of the acquired entities in a spin out of these entities, which involves among other issues, special purpose financing arranged through an Indian private equity fund and coordinating U.S. and Indian tax and securities laws.
  • Our lawyers represented a venture capital fund in its collaboration with a publicly traded Dutch company and a US executive in developing a web-based gaming site in the United Kingdom.
RESOURCES

Happenings, headlines and insights.
See what’s new at Davis Malm.

View Our Business Resources

Publications

August 28, 2020

How Businesses Can Reopen in Compliance With the ADA

Read More

Publications

August 25, 2020

Massachusetts Travels the Long and Winding Road to Social Equity in Cannabis

Read More

Publications

August 13, 2020

New Guidance for Tax-Exempt Organizations: Proposed IRC 4960 Regulations

Read More

Publications

August 10, 2020

Significant Massachusetts Tax Developments Over the Last Year

Read More

Alerts

August 4, 2020

Delivery-Only Cannabis License Applications Are Open in Massachusetts

Read More

Publications

July 8, 2020

Phil Olsen Serves as Contributing Author for 2019-2020 ABA Sales & Use Tax Deskbook

Read More

Speaking Engagements

June 12, 2020

Annual Massachusetts Tax Update

Read More

Alerts

May 19, 2020

Massachusetts Businesses Get the Green Light to Open

Read More

Publications

May 13, 2020

What Financial Advisors Need to Know About Tax Relief Provisions Under the CARES Act

Read More
Contact Us

Need Business Counsel?

Get in touch
Scroll to Top